Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Pediatr Hematol Oncol. 2022 May 3;40(1):14–25. doi: 10.1080/08880018.2022.2069894

Table 1:

Sociodemographics (N=107)

N %
IRB Role (check all)
Chair 24 22.4
Lawyer 1 0.9
Ethicist 9 8.4
Researcher 22 20.6
Clinician 13 12.2
Community member 12 11.2
Patient advocate 5 4.7
Non-scientist 29 27.1
Other 18 16.8
Missing 24
Years of IRB membership
Less than 5 years 33 32.4
5–10 years 27 26.5
11–15 years 16 15.7
More than 15 years 26 25.5
Missing 5
Number of pediatric studies reviewed
None 5 4.9
Less than 10 22 21.6
10–20 13 12.7
21–50 13 12.7
More than 50 49 48.0
Missing 5
IRB affiliation (check all)
Academic/university 56 52.3
Government 7 6.5
Hospital 60 56.1
Commercial 6 5.6
NGO 10 9.4
Tribal 0 0.0
Other 2 1.9
Gender Identity
Man 30 29.4
Woman 72 70.6
Missing 5
Race (check all)
White 92 86.8
Black or African American 3 2.8
American Indian or Alaska Native 2 1.9
Asian 5 4.7
Native Hawaiian/Pacific Islander 0 0.0
Other 3 2.8
Prefer not to say 1 .94
Missing 1
Ethnicity
Hispanic 4 3.9
Non-hispanic 97 95.1
Prefer not to say 1 1.0
Missing 5
Any children?
No 30 29.4
Yes 72 70.6
Missing 5
Any children have a serious illness?
No 46 64.0
Yes 26 36.0
No children 30
Missing 5
Enrolled yourself in research?
No 50 49.0
Yes 52 51.0
Missing 5
Enrolled a child in research?
No 54 75.0
Yes 18 25.0
No children 30
Missing 5